Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · April 24, 2024

Efficacy and Safety of GLP-1 Receptor Agonists in Familial Partial Lipodystrophy

Diabetes Care


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes Care
Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy
Diabetes Care 2024 Apr 01;47(4)653-659, MC Foss-Freitas, S Imam, A Neidert, AD Gomes, DT Broome, EA Oral

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading